Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01610661 · ClinicalTrials.gov registry record · NA

Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators

A NA study of Dyslipidemia, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT01610661: Completed NA study of Dyslipidemia, sponsored by Tufts University.

NCT01610661 is a NA study of Dyslipidemia that has completed, run by Tufts University. The registered enrollment target is 10 participants, below the 363-participant average among 40 other Dyslipidemia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01610661, a NA study of Dyslipidemia, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the effect of habituation to diets with different types of carbohydrate (simple-carb, refined-carb, unrefined-carb) on selected Cardiovascular Disease (CVD) risk indicators.

Conditions Studied

Interventions

  • OTHER Diet

Study Locations (1)

Massachusetts

  • Jean Mayer Human Nutrition Research Center on Aging - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2012-01
Est. Completion 2017-12
Phase NA
Tufts University

163 total trials

What the finished NCT01610661 record still lists

NCT01610661 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 363-participant average among 40 other Dyslipidemia trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 1 intervention - of which Diet is the first listed.

NCT01610661 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01610661 about?

NCT01610661 is a clinical study titled "Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators". The aim of this study is to determine the effect of habituation to diets with different types of carbohydrate (simple-carb, refined-carb, unrefined-carb) on selected Cardiovascular Disease (CVD) risk indicators.

What is the current status of trial NCT01610661?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2012-01. Estimated completion is 2017-12.

What conditions does trial NCT01610661 study?

This clinical trial studies the following conditions: Dyslipidemia.

What interventions are being tested in trial NCT01610661?

The interventions under investigation include: Diet (OTHER).

Who is sponsoring clinical trial NCT01610661?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01610661 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dyslipidemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01610661's enrollment target sits among peer trials

10 40th of 40 higher than 1 of 40 other Dyslipidemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dyslipidemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01610661, the US trial registry maintained by the National Library of Medicine. NCT01610661 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.